In the absence of head-to-head studies, oncologists are looking across pivotal trials and are encouraged by Itovebi's safety and efficacy versus Piqray.

Expert Rev Clin Pharmacol. 2012;5(3):319-336. Finally, a recent study suggested that although prasugrel significantly reduces thrombotic events in patients with ACS undergoing PCI because of its ...

Targeting the ER and PI3K pathway: Novel drugs and combinations Date/Time: Wednesday, December 11, 8:00-9:30 a.m. ET (7:00-8:30 a.m. CT) Data support planned initiation of Phase 3 pivotal trial ...

Zhejiang Province Key Laboratory of Smart Management & Application of Modern Agricultural Re-sources, School of Information Engineering, Huzhou University, Huzhou 313000, Zhejiang Province,China ...

College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi 712100, P.R. China Guangdong Provincial Key Laboratory of Food Quality and Safety, South China Agricultural ...

phosphoinositide 3-kinase (PI3K), sphingosine kinase (SphK), phospholipase C (PLC) and PLD function upstream of the activation of phospholipase A2 (PLA2), prostaglandin H2 synthase (PGH2S ...

Bone remodeling is a complex process involving the coordinated actions of osteoblasts and osteoclasts to maintain bone homeostasis. While the influence of osteoblasts on osteoclast differentiation is ...

Phosphoinositide phosphates (PIPs) are lipids that can convey distinct identities to different cellular membranes via different phosphorylation patterns. Here, Lebecq, Doumane, and co-authors document ...